Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-25

Clinical Trial Update: Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine [EARLY_Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating whether a patient education/messaging platform increases uptake and completion of the HPV vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Regenstrief Institute, Inc. | Conditions: Human Papilloma Virus Infection Type 11, Human Papilloma Virus Infection Type 16 | EARLY_Phase 1 | Status: COMPLETED